Literature DB >> 20473792

Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings.

A Spaar1, C Graber, F Dabis, A Coutsoudis, L Bachmann, J McIntyre, M Schechter, H W Prozesky, S Tuboi, D Dickinson, N Kumarasamy, M Pujdades-Rodriquez, E Sprinz, H J Schilthuis, P Cahn, N Low, M Egger.   

Abstract

Expanded access to antiretroviral therapy (ART) offers opportunities to strengthen HIV prevention in resource-limited settings. We invited 27 ART programmes from urban settings in Africa, Asia and South America to participate in a survey, with the aim to examine what preventive services had been integrated in ART programmes. Twenty-two programmes participated; eight (36%) from South Africa, two from Brazil, two from Zambia and one each from Argentina, India, Thailand, Botswana, Ivory Coast, Malawi, Morocco, Uganda and Zimbabwe and one occupational programme of a brewery company included five countries (Nigeria, Republic of Congo, Democratic Republic of Congo, Rwanda and Burundi). Twenty-one sites (96%) provided health education and social support, and 18 (82%) provided HIV testing and counselling. All sites encouraged disclosure of HIV infection to spouses and partners, but only 11 (50%) had a protocol for partner notification. Twenty-one sites (96%) supplied male condoms, seven (32%) female condoms and 20 (91%) provided prophylactic ART for the prevention of mother-to child transmission. Seven sites (33%) regularly screened for sexually transmitted infections (STI). Twelve sites (55%) were involved in activities aimed at women or adolescents, and 10 sites (46%) in activities aimed at serodiscordant couples. Stigma and discrimination, gender roles and funding constraints were perceived as the main obstacles to effective prevention in ART programmes. We conclude that preventive services in ART programmes in lower income countries focus on health education and the provision of social support and male condoms. Strategies that might be equally or more important in this setting, including partner notification, prompt diagnosis and treatment of STI and reduction of stigma in the community, have not been implemented widely.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473792      PMCID: PMC2888993          DOI: 10.1080/09540120903349102

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  28 in total

1.  Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention.

Authors:  Helene Gayle; Joep M A Lange
Journal:  Lancet       Date:  2004 Jul 3-9       Impact factor: 79.321

2.  Behaviour change in HIV infected subjects following health education.

Authors:  A V Rao; R Swaminathan; S Baskaran; C Belinda; G Andal; K Saleem
Journal:  Indian J Med Res       Date:  1991-11       Impact factor: 2.375

Review 3.  Strategies for partner notification for sexually transmitted diseases.

Authors:  C Mathews; N Coetzee; M Zwarenstein; C Lombard; S Guttmacher; A Oxman; G Schmid
Journal:  Cochrane Database Syst Rev       Date:  2001

4.  Free formula milk for infants of HIV-infected women: blessing or curse?

Authors:  A Coutsoudis; A E Goga; N Rollins; H M Coovadia
Journal:  Health Policy Plan       Date:  2002-06       Impact factor: 3.344

5.  Positive and negative life events after counselling and testing: the Voluntary HIV-1 Counselling and Testing Efficacy Study.

Authors:  O A Grinstead; S E Gregorich; K H Choi; T Coates
Journal:  AIDS       Date:  2001-05-25       Impact factor: 4.177

6.  Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people.

Authors:  S C Kalichman; D Rompa; M Cage; K DiFonzo; D Simpson; J Austin; W Luke; J Buckles; F Kyomugisha; E Benotsch; S Pinkerton; J Graham
Journal:  Am J Prev Med       Date:  2001-08       Impact factor: 5.043

7.  Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality.

Authors: 
Journal:  Lancet       Date:  2000-02-05       Impact factor: 79.321

8.  Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group.

Authors: 
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

9.  Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings.

Authors:  Mathieu Forster; Christopher Bailey; Martin W G Brinkhof; Claire Graber; Andrew Boulle; Mark Spohr; Eric Balestre; Margaret May; Olivia Keiser; Andreas Jahn; Matthias Egger
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

Review 10.  HIV-1/AIDS and maternal and child health in Africa.

Authors:  François Dabis; Ehounou René Ekpini
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

View more
  13 in total

1.  Tuberculosis in HIV programmes in lower-income countries: practices and risk factors.

Authors:  L Fenner; M Forster; A Boulle; S Phiri; P Braitstein; C Lewden; M Schechter; N Kumarasamy; M Pascoe; E Sprinz; D R Bangsberg; P S Sow; D Dickinson; M P Fox; J McIntyre; M Khongphatthanayothin; F Dabis; M W G Brinkhof; R Wood; M Egger
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

2.  Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa.

Authors:  Richard J Lessells; Portia C Mutevedzi; Graham S Cooke; Marie-Louise Newell
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

3.  Nothing can defeat combined hands (Abashize hamwe ntakibananira): protective processes and resilience in Rwandan children and families affected by HIV/AIDS.

Authors:  Theresa Stichick Betancourt; Sarah Meyers-Ohki; Sara N Stulac; Amy Elizabeth Barrera; Christina Mushashi; William R Beardslee
Journal:  Soc Sci Med       Date:  2011-07-23       Impact factor: 4.634

4.  Relationships Among Adherence and Physical and Mental Health Among Women Living with HIV in Rural India.

Authors:  Adeline Nyamathi; Maria Ekstrand; Elsa Heylen; Padma Ramakrishna; Kartik Yadav; Sanjeev Sinha; Angela Hudson; Catherine L Carpenter; Lenore Arab
Journal:  AIDS Behav       Date:  2018-03

5.  Direct questioning is more effective than patient-initiated report for the detection of sexually transmitted infections in a primary care HIV clinic in Western Kenya.

Authors:  Victoria Gah Hay Woo; Craig R Cohen; Elizabeth A Bukusi; Megan J Huchko
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

6.  Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada.

Authors:  Viviane D Lima; Robert S Hogg; Julio S G Montaner
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

7.  Correlates of Adherence among Rural Indian Women Living with HIV/AIDS.

Authors:  Adeline Nyamathi; Benissa Salem; E J Ernst; Colleen Keenan; P Suresh; Sanjeev Sinha; Kalyan Ganguly; Padma Ramakrishnan; Yihang Liu
Journal:  J HIV AIDS Soc Serv       Date:  2012

8.  Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries.

Authors:  Catherine Henley; Gideon Forgwei; Thomas Welty; Matthew Golden; Adaora Adimora; Raymond Shields; Pius Tih Muffih
Journal:  Sex Transm Dis       Date:  2013-12       Impact factor: 2.830

9.  "If the patients decide not to tell what can we do?"- TB/HIV counsellors' dilemma on partner notification for HIV.

Authors:  Barnabas N Njozing; Kerstin E Edin; Miguel San Sebastián; Anna-Karin Hurtig
Journal:  BMC Int Health Hum Rights       Date:  2011-06-03

10.  A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa--the International epidemiologic Databases to Evaluate AIDS (IeDEA).

Authors: 
Journal:  J Int AIDS Soc       Date:  2013-01-15       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.